Cryoport, Inc. — Director's Dealing 2024

Mar 20, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2024-03-09

Reporting Person: Sawicki Mark W (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-09	Common Stock	M	2666	—	Acquired	75791	Direct
2024-03-11	Common Stock	S	1418	$16.3524	Disposed	74373	Direct
2024-03-15	Common Stock	S	1312	$15.4322	Disposed	73061	Direct
2024-03-15	Common Stock	A	5750	—	Acquired	78811	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-09	Restricted Stock Rights	$	M	2666	Disposed		Common Stock (2666)	Direct
2024-03-15	Stock Option (right to buy)	$16.70	A	11500	Acquired	2031-03-15	Common Stock (11500)	Direct

Footnotes

F1: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F2: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

F3: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025.

F4: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024.

F5: 1/48 of options vest on the 15th of each month for forty-eight months beginning April 25, 2024.